about
A chemical-inducible CRISPR-Cas9 system for rapid control of genome editing.Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.Galectin-3 regulates hepatic progenitor cell expansion during liver injury.Author Correction: Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responsesMetabolism as a guiding force for immunityGlycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responsesA variant in IL6ST with a selective IL-11 signaling defect in human and mouse
P50
Q34540074-B53E8349-CCDB-44CE-9F4F-758D993F368AQ39940199-026E48A6-C731-4ED8-9F7F-3A0FEB1207E5Q46197743-863988A9-B519-4A42-8A79-3851433AB9E5Q51722974-07348F9F-C21E-4655-BE83-3CDB7F7FE557Q90262804-872C4157-0310-47F8-9D1B-357C93A1EFCFQ90854388-9A05A378-BE78-4836-96D1-059400190B40Q92432967-6E27C0B7-8DCF-4D1E-8245-6A7DF71FE729Q96607785-48343E61-4CA0-448A-A337-9EECCAC8A482
P50
description
researcher (ORCID 0000-0003-0674-9066)
@en
name
Jonathan Jung
@en
type
label
Jonathan Jung
@en
prefLabel
Jonathan Jung
@en
P31
P496
0000-0003-0674-9066